BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37635140)

  • 1. Association of Tumor Necrosis Factor-Alpha with Psychopathology in Patients with Schizophrenia.
    Pavlovic M; Babic D; Rastovic P; Arapovic J; Martinac M; Jakovac S; Barbaric R
    Acta Med Okayama; 2023 Aug; 77(4):395-405. PubMed ID: 37635140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.
    Lv MH; Tan YL; Yan SX; Tian L; Chen DC; Tan SP; Wang ZR; Yang FD; Yoon JH; Zunta-Soares GB; Soares JC; Zhang XY
    Psychopharmacology (Berl); 2015 Jan; 232(1):165-72. PubMed ID: 24958229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia.
    Tian L; Tan Y; Chen D; Lv M; Tan S; Soares JC; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():259-64. PubMed ID: 24995685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients.
    Lin C; Chen K; Yu J; Feng W; Fu W; Yang F; Zhang X; Chen D
    BMC Psychiatry; 2021 Nov; 21(1):561. PubMed ID: 34763685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia.
    Dunjic-Kostic B; Jasovic-Gasic M; Ivkovic M; Radonjic NV; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Petronijevic ND
    Psychiatr Danub; 2013 Mar; 25(1):55-61. PubMed ID: 23470607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia.
    Yang H; Peng R; Yang M; Zhang J; Shi Z; Zhang X
    BMC Psychiatry; 2024 Mar; 24(1):173. PubMed ID: 38429778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia.
    Turhan L; Batmaz S; Kocbiyik S; Soygur AH
    Nord J Psychiatry; 2016 Jul; 70(5):342-50. PubMed ID: 26754110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study).
    Strzelecki D; Urban-Kowalczyk M; Wysokiński A
    Psychiatry Res; 2018 Oct; 268():447-453. PubMed ID: 30130712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α (TNF-α) levels in patients with schizophrenia.
    Gül Çakıl A; Kaya H; Sakallı Nural A; Çakmak IB; Okay İT; Göka E
    Psychopharmacology (Berl); 2023 May; 240(5):1091-1101. PubMed ID: 36877232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine.
    Ajami A; Abedian F; Hamzeh Hosseini S; Akbarian E; Alizadeh-Navaei R; Taghipour M
    Iran J Immunol; 2014 Sep; 11(3):200-9. PubMed ID: 25265997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines.
    Pae CU; Yoon CH; Kim TS; Kim JJ; Park SH; Lee CU; Lee SJ; Lee C; Paik IH
    Int Immunopharmacol; 2006 Apr; 6(4):666-71. PubMed ID: 16504930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics.
    Zhang XY; Cao LY; Song C; Wu GY; Chen DC; Qi LY; Wang F; Xiu MH; Chen S; Zhang Y; Lu L; Kosten TA; Kosten TR
    Psychopharmacology (Berl); 2008 Dec; 201(3):383-9. PubMed ID: 18719893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of BDNF, VEGF, TNF-α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients.
    Chukaew P; Bunmak N; Auampradit N; Siripaiboonkij A; Saengsawang W; Ratta-Apha W
    Neuropsychopharmacol Rep; 2022 Sep; 42(3):281-287. PubMed ID: 35733332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reduction of CSF tumor necrosis factor alpha levels in schizophrenia: no correlations with psychopathology and coincident metabolic characteristics.
    Zhu H; Wang D; Liu X
    Neuropsychiatr Dis Treat; 2016; 12():2869-2874. PubMed ID: 27843322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
    Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
    Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment.
    Ribeiro-Santos R; de Campos-Carli SM; Ferretjans R; Teixeira-Carvalho A; Martins-Filho OA; Teixeira AL; Salgado JV
    Nord J Psychiatry; 2020 Apr; 74(3):187-193. PubMed ID: 31738648
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls.
    Kubistova A; Horacek J; Novak T
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S153-6. PubMed ID: 22945211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of olfactory function, cognitive function and serum tumor necrosis factor-α between bipolar and schizophrenic patients in the remission stage.
    Su L; Liu X; Li Y; Yuan H; Li Q; Li C
    BMC Psychiatry; 2023 Nov; 23(1):811. PubMed ID: 37936082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics.
    Dong R; Zhao NO; Wu HE; Yu L; Zhang XY
    J Psychiatr Res; 2021 Jun; 138():492-499. PubMed ID: 33971483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.